Baijin Life Science Holdings Ltd. is a biopharmaceutical company with a strong focus on anti-aging, preventive medicine, and cellular precision therapy. Its operations span the research and development of cellular and large molecule drugs, clinical research services, and the development and sale of its proprietary skincare brand. The company serves a crucial role in advancing therapies aimed at age-related health concerns and preventative healthcare solutions, reflecting the growing global demand for innovative treatments in longevity and wellness. By integrating research, development, and product commercialization, Baijin Life Science Holdings Ltd. contributes significantly to the evolving landscape of biotechnology and medical science, particularly in sectors addressing chronic conditions and enhancing quality of life through cutting-edge therapeutic solutions.
Markedsdata leveret af TwelveData og Morningstar